Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes
NCT00737776
·
clinicaltrials.gov ↗
COMPLETED
Status
1068
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Interventions
DRUG:
biphasic insulin aspart 30
Sponsor
Novo Nordisk A/S